MedPage Today on MSN
Multicomponent test tops PSA for clinically significant prostate cancers
Blood-based biomarker test had similar false-positive rate as PSA, while reducing false ne ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Toric soft contact lens prescribing increased from 24.4% ...
BARCELONA, Spain — For the first time in a decade, diagnostic criteria for neuromyelitis optica spectrum disorder (NMOSD) are being overhauled, with changes that redefine the condition and its ...
Implementation of universal germline testing in underserved patients with young onset gastrointestinal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
Differences across blood pressure (BP) measurement methods show clinically important variance in readings, according to a review published online in the Annals of Internal Medicine. Jiunn-Tyng Yeh, ...
Daily Mail on MSN
New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds
A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.
Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65-85 living with moderate or greater valvular heart disease (VHD) in the United States, and at ...
Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall ...
FutureCeuticals, Inc. is pleased to announce the peer-reviewed publication of clinical research demonstrating unique energy, performance, and metabolic benefits of Caffinity™, a proprietary ingredient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results